Sodium Phenylbutyrate (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Sodium Phenylbutyrate drug offered from Par Pharmaceutical, Inc.. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Sodium Phenylbutyrate Tablets, 500 mg |
| SUBSTANCE NAME: | SODIUM PHENYLBUTYRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-04-29 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Phenylbutyrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Phenylbutyrate from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2016-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49884-170_682dc4ca-6e05-435d-bc94-708d19acdea8 |
| PRODUCT NDC: | 49884-170 |
| APPLICATION NUMBER: | ANDA204395 |
Other SODIUM PHENYLBUTYRATE Pharmaceutical Manufacturers / Labelers:
